Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Compounding of another big-selling GLP-1 drug – Eli Lilly's tirzepatide – was blocked in December after that also ... determined the shortage of semaglutide injection products, a glucagon ...